Published in Cancer Weekly, February 3rd, 1997
2-ME, a natural estrogen metabolite, was discovered by Dr. Robert D'Amato and colleagues at Children's Hospital, Boston, Massachusetts, to inhibit the growth of breast cancer cells and to block angiogenesis.
In collaborative pre-clinical trials with the U.S. National Cancer Institute (NCI), Bethesda, Maryland, it was shown that 2-ME acts similarly to Taxol, inhibiting cellular machinery involved in replicating cancer cells. 2-ME also is an anti-angiogenic agent that prevents the growth of new...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.